(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Mary Moriarty, International Falls and the University of Minnesota Dance team round out a week of Cheers & Jeers.

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

One in five Irish people said they would not take a traditional vaccine, a worldwide research project found. A further one in ...

In particular, hedge fund managers, using their vast resources and analytical capabilities, are more receptive to such ...

​This article will examine 20 takeover rumors that have prompted hedge funds to buy stocks.

SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...